Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
Status:
Recruiting
Trial end date:
2025-11-29
Target enrollment:
Participant gender:
Summary
The purpose of this research is to test the safety and effectiveness of the investigational
combination of Troriluzole, ipilimumab, and nivolumab, and to learn whether this combination
works in treating melanoma that has spread to the brain.